Obesity Drug Coverage Could Boost Spending By $35B Through 2034: CBO
Go back to Obesity Drug Coverage Could Boost Spending By $35B Through 2034: CBO| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1280.34 +54.61 (4.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1225.73 | 52 Week High | $88.16 | |||
| Open | $1245.81 | 52 Week Low | $67.88 | |||
| Day High | $1292.65 | P/E | 296.38 | |||
| Day Low | $1240.54 | EPS | $4.32 | |||
| Volume | 4,402,710 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.48 +0.77 (1.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.71 | 52 Week High | $59.00 | |||
| Open | $46.01 | 52 Week Low | $32.80 | |||
| Day High | $47.20 | P/E | N/A | |||
| Day Low | $45.84 | EPS | $0.00 | |||
| Volume | 19,443,680 | |||||
